The Lattice Brief
Curated news and clear-eyed analysis on 3D technologies and advanced manufacturing across healthcare — from 3D printing and bioprinting to surgical planning, digital workflows, and the regulatory signals that move them. A monthly roundup for the founders, clinicians, and investors shaping the field.
What’s inside each issue
A predictable structure so you can scan it in minutes and know exactly where to look.
The big thing
One story that matters, with the commercial or clinical read — not just a headline.
Regulatory watch
New FDA 510(k) clearances and regulatory signals across healthcare manufacturing.
Funding & deals
Raises, acquisitions, and partnerships moving the healthcare manufacturing market.
Clinical & research
Peer-reviewed findings and clinical milestones, translated into plain language.
From 3DHEALS
The month’s Lattice podcast, new research, and upcoming events worth your time.
The latest brief
From bioprinted organs to FDA-cleared implants
The big thing
Bioprinting was the month’s center of gravity — and it’s moving toward organ scale
March’s most active area was bioprinting, with advances spanning reproductive medicine, oncology, and organ-scale tissue engineering. The throughline: work is shifting from in-vitro models toward tissues built for therapeutic use, and the supporting layers — sustainable bioinks, vascularization, and volumetric printing — are maturing alongside it.
Analysis · 3DHEALSRegulatory watch
- Titanium spinal implant. A new FDA 510(k)-cleared titanium spinal implant landed amid shifting trends in lumbar cage materials and coatings. 510(k)
- 3D Systems dentures. Full EU MDR certification for its jetted denture solution; following a 2025 U.S. launch, the company plans European entry by summer 2026. EU MDR
Funding & deals
- ENLIGHT pancreas project. Rousselot’s X-Pure gelatin bioinks anchor a €3.6M EU-backed, pan-European consortium — including UMC Utrecht, ETH Zürich, and EPFL — using volumetric bioprinting toward a functional pancreas for diabetes research.
Clinical & research
- Bioprinted uterus model. A UNR School of Medicine team, using Aspect Biosystems tissue therapeutics, built a model mimicking the late-pregnancy human uterus to test preterm-labor drugs without human subjects.
- 3D-printed breast cancer locator. Patient-specific printed guides improved surgical margins in breast-conserving oncology.
From 3DHEALS
The archive
A permanent record of the healthcare 3D and advanced-manufacturing month — searchable, citable, and always at the same address.
Advanced devices, custom eyewear, and the hidden health risks of 3D printing Materials
Printer emissions and safeguards, implant surfaces and coatings, microfluidics, and space-based biomanufacturing.
ARPA-H organ “moonshots” and point-of-care manufacturing Bioprinting
Multi-institutional ARPA-H liver bioprinting grants, POC printing spreading through hospitals, and the deepened Aspect–Novo Nordisk diabetes pact.
Get the brief every month.
Five minutes of curated healthcare 3D and advanced-manufacturing intelligence, in your inbox.